LJankowiak
TL3 Regular · Madrid, ES
Laboratory background. Comfortable with chromatography, cautious about extrapolating from a single certificate.
Joined 23 November 2024 · last posted 2h · groups: analytical-chemists
141 posts, newest first. Showing up to 150.
-
Request: a per-category review queue Replied, post #137 · Meta › Feature requests · 28 Jul 2026 · 3 likes Coming back to post #135, because the follow-up matters more than the original answer. Deprecation requests: if you think a feature should be removed or changed, that…
-
Pooling trials with different estimands Replied, post #131 · Evidence › Meta-analyses · 26 Jul 2026 · 0 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #15 · Clinical › Bloodwork · 19 Jul 2026 · 31 likes This follows post #12 rather than contradicting it. TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If…
-
How shortages have affected compounding permissions — does this still hold? Replied, post #27 · Access › Shortages · 17 Jul 2026 · 10 likes post #26 answers the question as asked. The question underneath it is different. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
GHRH analogues versus ghrelin mimetics: different mechanisms, conflated discussion Replied, post #45 · Compounds › Secretagogues & GH axis · 16 Jul 2026 · 1 like Picking up post #42: that is the part I would want checked first. Development history is more informative than speculation: ipamorelin was investigated clinically for…
-
Here for the analytics and not much else Replied, post #34 · Lounge › Introductions · 14 Jul 2026 · 4 likes Community culture: introductions give you a sense of who is here. Reading a few introduces you to the people and the tone of the community.
-
Request: a per-category review queue Replied, post #102 · Meta › Feature requests · 14 Jul 2026 · 0 likes On post #98 — agreed on the reasoning, with one qualification. Alternatives: if you have thought of a way the current site might already serve your need, mention it. It…
-
Immortal time bias in a claims-database study — one year on Replied, post #18 · Evidence › Study critique · 11 Jul 2026 · 7 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
How much context is too much context in a first post? Replied, post #45 · Start Here › How to Ask · 8 Jul 2026 · 0 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #60 · Evidence › Journal club · 7 Jul 2026 · 10 likes post #59 is right about the mechanism and I think understates the practical bit. Session format: read the paper before posting. The discussion is much better when…
-
Revisiting: The report format the maintainers ask for, and why each field is there Replied, post #97 · Sourcing › Vendor reports · 7 Jul 2026 · 21 likes Worth separating two things that post #93 runs together. Testing service selection: Janoshik gives purity with chromatogram. Medutest gives combined purity and…
-
Sleep quality changes during weight loss Replied, post #11 · Wellbeing › Sleep · 6 Jul 2026 · 0 likes On post #7 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
What a good consultation looks like from the other side Replied, post #56 · Clinical › Prescriber conversations · 5 Jul 2026 · 0 likes Questions about dose: asking "how will we determine whether this dose is working for me" gets at the monitoring plan. Asking "can we start lower" or "can we escalate…
-
Insurance and replacement policies, compared Replied, post #64 · Sourcing › Logistics · 5 Jul 2026 · 3 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
Request: a per-category review queue Replied, post #69 · Meta › Feature requests · 30 Jun 2026 · 0 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Revisiting: Why the absence of controlled human data on BPC-157 matters more than people… Replied, post #3 · Compounds › Repair & healing peptides · 27 Jun 2026 · 0 likes BPC-157: the preclinical literature is extensive, mostly from a small number of research groups, and reports effects across a wide range of injury models. The breadth…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #27 · Pharmacology › Receptor biology · 25 Jun 2026 · 4 likes Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors. Semaglutide has some activity on other receptors; tirzepatide…
-
Why we ask for units every single time, with three examples of what goes wrong Replied, post #62 · Start Here › How to Ask · 22 Jun 2026 · 24 likes Questions you cannot explain: "I cannot say why I am asking this, but is this compound stable at room temperature?" is more productive than no question at all. People…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #44 · Analytics › HPLC & UHPLC · 18 Jun 2026 · 1 like post #43 answers the question as asked. The question underneath it is different. System suitability testing: injections run before and during the sample run to…
-
Chain of custody for a sample you posted yourself — one year on Replied, post #24 · Sourcing › Independent verification · 13 Jun 2026 · 5 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
A site rotation scheme that is easy enough to actually follow Replied, post #86 · Practice › Administration · 12 Jun 2026 · 12 likes Coming back to post #84, because the follow-up matters more than the original answer. Leak-back after withdrawal: a small amount of liquid on the skin after withdrawal…
-
Follow-up: Sleep quality changes during weight loss Replied, post #38 · Wellbeing › Sleep · 5 Jun 2026 · 20 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Revisiting: Mean kinetic temperature explained without the mathematics Replied, post #27 · Practice › Storage & stability · 31 May 2026 · 32 likes I want to gently push back on the reply above about storage extrapolation. The advice is sound and the confidence is not. We are extrapolating from stability data on a…
-
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #67 · Practice › Administration · 24 May 2026 · 16 likes Worth separating two things that post #63 runs together. Two things before anyone answers the substance. First, the context in the first post is clear and specific.…
-
Insomnia at a dose step: reported experiences — the long version Replied, post #25 · Wellbeing › Sleep · 23 May 2026 · 24 likes Stimulants and sleep: if supplementing with caffeine or other stimulants for energy during weight loss, timing and dose matter for sleep. Evening stimulant use…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #54 · Practice › Reconstitution · 15 May 2026 · 4 likes post #53 is right about the mechanism and I think understates the practical bit. Over-dilution: if your target dose is 0.25 mg and your syringe is a 1 mL insulin…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #123 · Compounds › Tirzepatide · 14 May 2026 · 0 likes post #122 answers the question as asked. The question underneath it is different. Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide,…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #36 · Safety › Contraindications · 12 May 2026 · 5 likes Disordered eating history: appetite suppression can trigger relapse in people with history of anorexia, bulimia, or other eating disorders. This is a relative…
-
Area percent versus weight percent: the confusion that causes most arguments Replied, post #7 · Analytics › HPLC & UHPLC · 2 May 2026 · 26 likes Picking up post #4: that is the part I would want checked first. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
[2026 update] Thyroid function tests during substantial weight change Replied, post #54 · Clinical › Bloodwork · 1 May 2026 · 12 likes I read post #52 twice before replying, because I had assumed the opposite. Analytical imprecision: any measurement has an error margin. A small difference in…
-
When a dose reduction is the correct response to a side effect Replied, post #16 · Practice › Dosing & titration · 28 Apr 2026 · 31 likes The arithmetic of an intermediate dose: if the label says 1.0 mg and 2.0 mg, a dose strictly between them is off-label by definition. Some people compute it anyway. The…
-
Journal club: is percentage weight change the right endpoint? Replied, post #108 · Evidence › Journal club · 27 Apr 2026 · 28 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Five questions in one post gets you one answer — how to split them Replied, post #61 · Start Here › How to Ask · 21 Apr 2026 · 0 likes post #60 is right about the mechanism and I think understates the practical bit. Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a…
-
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #90 · Compounds › Tirzepatide · 20 Apr 2026 · 29 likes This follows post #87 rather than contradicting it. Storage and stability: published data on licensed tirzepatide formulations exists and is worth reading directly…
-
[2026 update] Charge states for a 4 kDa peptide, worked through Replied, post #88 · Analytics › Mass spectrometry · 17 Apr 2026 · 18 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Validating a calculator against hand arithmetic Replied, post #17 · Data & Tools › Calculators · 11 Apr 2026 · 1 like This follows post #14 rather than contradicting it. Dose equivalence calculator: compounds have different potencies. The calculator is provided with a caveat:…
-
The anatomy of a question that gets answered within an hour Replied, post #11 · Start Here › How to Ask · 4 Apr 2026 · 0 likes Picking up post #8: that is the part I would want checked first. What you have already read matters. Saying "I read the maintained page on this and I still have a gap"…
-
Cold solution and stinging: the simplest fix Replied, post #12 · Practice › Administration · 31 Mar 2026 · 31 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Getting a referral rather than a refusal Replied, post #9 · Clinical › Prescriber conversations · 23 Mar 2026 · 11 likes Coming back to post #7, because the follow-up matters more than the original answer. Preparing for an appointment: bring recent bloodwork, a list of current medications…
-
[2026 update] Are there stupid questions here? A staff answer, at length Replied, post #25 · Start Here › Welcome · 15 Mar 2026 · 11 likes This follows post #22 rather than contradicting it. The FAQ link in the sidebar is maintained and worth ten hours of forum browsing. It is not comprehensive but it is…
-
Transporting a vial for a weekend away — a second dataset Replied, post #7 · Practice › Storage & stability · 14 Mar 2026 · 0 likes Container choice matters: the material of the vial, the rubber closure, the fill volume all affect how quickly the contents degrade. Smaller fill volumes lose less to…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #75 · Compounds › Semaglutide · 7 Mar 2026 · 2 likes post #74 is right about the mechanism and I think understates the practical bit. Is there a ceiling dose beyond which the effect plateaus? The trials did not study that…
-
Second pass at: What to keep a record of at the point of payment Replied, post #14 · Sourcing › Payments · 27 Feb 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #52 · Analytics › Impurities & related substances · 26 Feb 2026 · 1 like Off-target structures: if the sequence synthesis goes wrong, a completely different amino acid can be incorporated. The resulting off-target peptide is a structural…
-
Measurement error in a self-reported exposure Started this topic · Evidence › Study critique · 21 Feb 2026 · 14 likes Posting this under the heading it deserves: Measurement error in a self-reported exposure Everything below is what sits behind that. Session topic: SURPASS-2 ( N Engl J…
-
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #72 · Practice › Dosing & titration · 18 Feb 2026 · 2 likes I read post #70 twice before replying, because I had assumed the opposite. How the published trials escalated: they used specific step sizes and intervals. The STEP…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #85 · Pharmacology › Pharmacokinetics · 17 Feb 2026 · 25 likes Half-life: semaglutide ≈ 165–184 hours (about a week). Tirzepatide ≈ 5 days. Liraglutide ≈ 13 hours. The half-life determines how much accumulation happens at steady…
-
Pregnancy and pregnancy planning: contraindication and washout Replied, post #45 · Clinical › Special populations · 17 Feb 2026 · 0 likes post #44 answers the question as asked. The question underneath it is different. Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds…
-
Second pass at: Identical chromatograms across two different lots Replied, post #7 · Sourcing › Red flags · 14 Feb 2026 · 7 likes This follows post #4 rather than contradicting it. Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still…
-
Trifluoroacetate content and its consequences Replied, post #133 · Analytics › Impurities & related substances · 11 Feb 2026 · 0 likes On post #129 — agreed on the reasoning, with one qualification. Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method.…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #94 · Clinical › Special populations · 6 Feb 2026 · 11 likes Worth separating two things that post #90 runs together. Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #35 · Compounds › Retatrutide · 29 Jan 2026 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #95 · Clinical › Special populations · 26 Jan 2026 · 0 likes Pancreatitis history: the compounds can rarely trigger pancreatitis. A history of pancreatitis makes monitoring for recurrence more important during titration.
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #76 · Clinical › Special populations · 25 Jan 2026 · 0 likes I read post #74 twice before replying, because I had assumed the opposite. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be…
-
Heterogeneity as information rather than as a nuisance Replied, post #64 · Evidence › Meta-analyses · 16 Jan 2026 · 27 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Pinch or no pinch, and how needle length changes the answer — the long version Replied, post #8 · Practice › Administration · 12 Jan 2026 · 0 likes Air bubbles in a subcutaneous injection: the honest risk assessment is low. Tiny air bubbles in subcutaneous tissue do not behave like an air embolism in a blood…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #52 · Pharmacology › Receptor biology · 11 Jan 2026 · 0 likes Amylin receptor signalling: amylin promotes satiety and slows gastric emptying through a receptor distinct from GLP-1. The hypothesis behind combination therapy is two…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #9 · Pharmacology › Pharmacokinetics · 5 Jan 2026 · 14 likes Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5 half-lives (about 4 to 5 weeks). Before that,…
-
Coverage in the US: a map of the usual obstacles Replied, post #27 · Regional › North America · 25 Dec 2025 · 22 likes Indigenous healthcare systems: different indigenous healthcare systems have different medication access. Pathways through tribal health systems differ from mainstream…
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #48 · Analytics › Method validation · 18 Dec 2025 · 6 likes Transfer between laboratories: a method can be transferred from one lab to another, but the receiving lab needs to demonstrate that they can achieve the same…
-
Tracking a preprint to publication: a worked example Replied, post #98 · Evidence › Preprints · 10 Dec 2025 · 0 likes What changes between preprint and publication: authors respond to reviewer comments, re-analyse data, correct errors found in peer review, and sometimes report…
-
DXA precision and the least significant change for lean mass Replied, post #48 · Outcomes › Body composition · 7 Dec 2025 · 18 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Started this topic · Pharmacology › Receptor biology · 2 Dec 2025 · 2 likes Posting this under the heading it deserves: Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long version Everything below is what sits…
-
Warfarin and altered intake: the monitoring argument — the long version Replied, post #59 · Practice › Interactions · 29 Nov 2025 · 0 likes I read post #57 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Sleep quality changes during weight loss — what changed since Replied, post #75 · Wellbeing › Sleep · 23 Nov 2025 · 21 likes Picking up post #72: that is the part I would want checked first. When sleep problems need attention: if sleep does not improve as weight loss continues or if it…
-
Sequence verification for an obscure compound: how it is done — what changed since Replied, post #16 · Compounds › Other compounds · 22 Nov 2025 · 1 like When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #13 · Clinical › Bloodwork · 19 Nov 2025 · 8 likes TSH and free hormones: TSH is a reasonable screening test but does not tell you about actual free hormone levels. If TSH is abnormal, free thyroid hormones confirm…
-
Severe gastroparesis and why this class is a poor fit — one year on Replied, post #4 · Safety › Contraindications · 13 Nov 2025 · 0 likes post #2 answers the question as asked. The question underneath it is different. Severe renal impairment (eGFR
-
Absolute versus relative contraindications Replied, post #4 · Safety › Contraindications · 9 Nov 2025 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #20 · Practice › Storage & stability · 7 Nov 2025 · 21 likes I read post #18 twice before replying, because I had assumed the opposite. Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades…
-
Follow-up: Why appetite effects are mostly central Replied, post #88 · Pharmacology › Receptor biology · 6 Nov 2025 · 0 likes Central versus peripheral action: GLP-1 agonism works through both central nervous system effects (appetite) and peripheral effects (gastric motility, insulin). The…
-
Stepping down deliberately, and how to do it without losing progress Replied, post #10 · Practice › Dosing & titration · 2 Nov 2025 · 27 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #24 · Start Here › How to Ask · 25 Oct 2025 · 1 like Arithmetic questions: write out the steps. "I have a 10 mg vial, I added 2 mL, I want a 0.25 mg dose, and I get this number for the syringe mark" is answerable. "How…
-
The anatomy of a question that gets answered within an hour — the long version Replied, post #15 · Start Here › How to Ask · 21 Oct 2025 · 0 likes Five questions in one post gets you one answer: the easiest one, usually not the one you needed most. Post them separately or pick the one that depends on the others…
-
Where to report an adverse event officially, by region — a second dataset Replied, post #13 · Safety › Adverse events · 11 Oct 2025 · 28 likes Pancreatitis is a genuine serious adverse event to know: severe epigastric pain, back pain, elevated lipase (≥3× upper limit of normal). If this constellation appears,…
-
The headache that turns out to be dehydration Replied, post #19 · Nutrition & Training › Hydration & electrolytes · 10 Oct 2025 · 19 likes The very ordinary causes of week-two malaise: inadequate hydration, low sodium intake, too-rapid calorie deficit, and inadequate sleep are more common causes of fatigue…
-
Lipase elevation without symptoms: the interpretation problem Replied, post #10 · Clinical › Bloodwork · 7 Oct 2025 · 23 likes HbA1c and glucose: HbA1c reflects average glucose over months; a spot glucose measurement reflects the moment. Trending glucose downward while HbA1c stays flat is a…
-
How to read a phase 2 result without treating it as a phase 3 result — what changed since Replied, post #8 · Compounds › Retatrutide · 7 Oct 2025 · 18 likes Worth separating two things that post #4 runs together. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #94 · Practice › Administration · 5 Oct 2025 · 20 likes I read post #92 twice before replying, because I had assumed the opposite. Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer…
-
Oral semaglutide bioavailability and its variability between people Replied, post #7 · Compounds › Oral incretins · 1 Oct 2025 · 18 likes This follows post #4 rather than contradicting it. Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no…
-
Second pass at: A history of disordered eating: proceeding carefully Replied, post #131 · Wellbeing › Mental health · 12 Sep 2025 · 23 likes This follows post #128 rather than contradicting it. Body image and weight loss: large weight loss changes a person's relationship with their body in ways that can be…
-
Coming back to: What published stability data actually covers, and what it does not Replied, post #137 · Practice › Storage & stability · 11 Sep 2025 · 2 likes On post #133 — agreed on the reasoning, with one qualification. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what…
-
About the Prescriber conversations category Replied, post #5 · Clinical › Prescriber conversations · 7 Sep 2025 · 13 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Follow-up: History of disordered eating and why it changes the conversation Replied, post #71 · Clinical › Special populations · 31 Aug 2025 · 0 likes Worth separating two things that post #67 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Research-use-only labelling: what it means and what it does not Replied, post #26 · Sourcing › Regulatory · 26 Aug 2025 · 4 likes Coming back to post #24, because the follow-up matters more than the original answer. Preclinical versus clinical: compounds with strong preclinical data can fail in…
-
When a preprint is the best available evidence and we say so Replied, post #60 · Evidence › Preprints · 15 Aug 2025 · 1 like Picking up post #57: that is the part I would want checked first. For anyone arriving from a search: the marked solution above is the direct answer, and the replies…
-
A request that was declined, and the reasoning — a second dataset Replied, post #62 · Documentation › Wiki requests · 12 Aug 2025 · 23 likes Authority and authorship: if you think a maintained page needs input from someone with specific expertise (a clinician, an analytical chemist) suggest who might…
-
Why oral semaglutide needs an absorption enhancer at all Replied, post #24 · Compounds › Oral incretins · 8 Aug 2025 · 6 likes Orforglipron is a small molecule, not a peptide. That changes almost everything: no absorption enhancer required, no fasting window, chemical synthesis instead of…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #7 · Practice › Administration · 2 Aug 2025 · 5 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #6 · Data & Tools › Datasets · 31 Jul 2025 · 16 likes Coming back to post #4, because the follow-up matters more than the original answer. Practical note that does not fit anywhere else. Whatever you conclude from this…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #12 · Analytics › Method validation · 4 Jul 2025 · 19 likes Worth separating two things that post #8 runs together. System suitability: injections run at the start of a batch to establish that the instrument and column are…
-
Persistent vomiting and the threshold for seeking help Started this topic · Safety › Adverse events · 27 Jun 2025 · 0 likes On the subject in the title: Persistent vomiting and the threshold for seeking help Working notes rather than a conclusion. General question, not a request for advice…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #141 · Compounds › Cagrilintide & amylin analogues · 26 Jun 2025 · 15 likes Picking up post #138: that is the part I would want checked first. Cagrilintide alone is discussed less than in combination because the published data is almost…
-
The CagriSema phase 2 paper and what a fixed combination buys — the long version Replied, post #90 · Compounds › Cagrilintide & amylin analogues · 14 Jun 2025 · 3 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #57 · Access › Insurance & coverage · 10 Jun 2025 · 5 likes Generic versus brand: most of these compounds do not have generic versions yet. Once they do, formulary coverage and pricing will shift.
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #21 · Pharmacology › Pharmacokinetics · 30 May 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #35 · Nutrition & Training › Protein & intake · 25 May 2025 · 3 likes Coming back to post #33, because the follow-up matters more than the original answer. Two things before anyone answers the substance. First, the context in the first…
-
Counter-ion content and its effect on measured mass Replied, post #43 · Analytics › Mass spectrometry · 20 May 2025 · 0 likes post #42 is right about the mechanism and I think understates the practical bit. Purity and identity are different questions: LC-MS establishes that the species at a…
-
A report I filed that turned out to be wrong, and the correction Replied, post #59 · Sourcing › Vendor reports · 18 May 2025 · 0 likes post #58 answers the question as asked. The question underneath it is different. Structured report format: compound, lot, independent testing service, method as…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #3 · Evidence › Journal club · 12 May 2025 · 11 likes On the opening post — agreed on the reasoning, with one qualification. FLOW (N Engl J Med 2024): Semaglutide renal outcomes in type 2 diabetes and chronic kidney…
-
A claim built entirely on a subgroup analysis Replied, post #29 · Evidence › Study critique · 11 May 2025 · 0 likes Multiple comparisons: if a paper reports many outcomes, the chance of a spurious association by random chance is real. Pre-specification of primary outcomes matters and…
-
Water content on a certificate and why it changes the arithmetic Replied, post #18 · Analytics › COA interpretation · 11 May 2025 · 7 likes Worth separating two things that post #14 runs together. Water content (residual moisture) matters: lyophilised peptide is not dry. A few percent water is normal. The…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #106 · Evidence › Journal club · 22 Apr 2025 · 0 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
[2026 update] Building a sensible monitoring schedule with your prescriber Replied, post #7 · Clinical › Bloodwork · 15 Apr 2025 · 0 likes This follows post #4 rather than contradicting it. Liver enzymes: elevation does not specify cause. ALT and AST can rise from many things. Bilirubin helps narrow down…
-
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #24 · Evidence › Journal club · 15 Apr 2025 · 19 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Talking to a therapist about this specifically — does this still hold? Replied, post #43 · Wellbeing › Mental health · 11 Apr 2025 · 6 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Scheduled maintenance and what will be unavailable Replied, post #101 · Meta › Announcements · 7 Apr 2025 · 0 likes post #100 answers the question as asked. The question underneath it is different. Feedback to announcements: if you have feedback on an announced change (not a…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #93 · Compounds › Cagrilintide & amylin analogues · 6 Apr 2025 · 0 likes post #92 is right about the mechanism and I think understates the practical bit. The CagriSema phase 2 paper: a fixed combination of the two components in one weekly…
-
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #74 · Devices › Cold chain · 26 Mar 2025 · 0 likes I read post #72 twice before replying, because I had assumed the opposite. Domestic refrigeration: most lyophilised peptides are stored at 2–8 °C (35–46 °F). That is…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #56 · Sourcing › Vendor reports · 16 Mar 2025 · 11 likes Structured report format: compound, lot, independent testing service, method as reported, result, and the certificate figure for the same lot. One lot is one lot. It…
-
Retatrutide dose escalation in the published trials Replied, post #15 · Compounds › Retatrutide · 15 Mar 2025 · 1 like Coming back to post #13, because the follow-up matters more than the original answer. Glucagon receptor agonism seems paradoxical in a weight-loss compound because…
-
Ipamorelin selectivity claims and where they came from Replied, post #19 · Compounds › Secretagogues & GH axis · 10 Mar 2025 · 8 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #49 · Practice › Reconstitution · 8 Mar 2025 · 19 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
When "no data" is the complete and final answer Replied, post #107 · Compounds › Other compounds · 2 Mar 2025 · 3 likes Worth separating two things that post #103 runs together. Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #71 · Analytics › Mass spectrometry · 27 Feb 2025 · 33 likes Quantitation by MS: most quantitation is done by LC-UV detection at 214 nm, not by MS, because extinction coefficients are better known. MS can quantify if an internal…
-
Distinguishing a deletion sequence by mass alone Replied, post #117 · Analytics › Mass spectrometry · 21 Feb 2025 · 8 likes Sample matrix effects: if a sample is dissolved in a complex matrix, other compounds in the matrix can suppress the peptide signal. Clean samples give higher…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual Replied, post #2 · Compounds › Tirzepatide · 19 Feb 2025 · 20 likes SURMOUNT-OSA is notable because it used an objective physiological endpoint, the apnoea-hypopnoea index, rather than a symptom scale. Two parallel trials, with and…
-
Reading an MS report that only gives you a single number Replied, post #7 · Analytics › Mass spectrometry · 8 Feb 2025 · 17 likes post #6 is right about the mechanism and I think understates the practical bit. Purity and identity are different questions: LC-MS establishes that the species at a…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #21 · Analytics › COA interpretation · 18 Jan 2025 · 12 likes I read post #19 twice before replying, because I had assumed the opposite. When method identifiers are missing: "reversed-phase HPLC" is less specific than…
-
A promotion I argued against, and why I lost Replied, post #65 · Documentation › Doc review · 18 Jan 2025 · 0 likes Promoted topic withdrawal: if a promoted topic becomes outdated or inaccurate and the maintainer does not update, requesting withdrawal is appropriate.
-
Amylin and gastric emptying: overlapping mechanisms with incretins Replied, post #2 · Compounds › Cagrilintide & amylin analogues · 12 Jan 2025 · 15 likes Coming back to the opening post, because the follow-up matters more than the original answer. The CagriSema phase 2 paper: a fixed combination of the two components in…
-
Oxidation pathways for methionine and tryptophan Replied, post #48 · Analytics › Impurities & related substances · 30 Dec 2024 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Reading a supplementary appendix and finding the interesting part Replied, post #51 · Evidence › Trials · 24 Dec 2024 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #21 · Compounds › Semaglutide · 20 Dec 2024 · 3 likes The opalescent appearance in semaglutide solutions is occasionally noted and the mechanism is unclear. It does not appear to correlate with product failure in practice.…
-
When to suspect the method rather than the sample Replied, post #51 · Analytics › Method validation · 15 Dec 2024 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Washout with a one-week half-life: the arithmetic Replied, post #45 · Research Methods › N-of-1 designs · 1 Dec 2024 · 0 likes On post #41 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #45 · Access › Insurance & coverage · 28 Nov 2024 · 0 likes I read post #43 twice before replying, because I had assumed the opposite. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write…
-
Follow-up: What this community means by "a source", in practical terms Replied, post #13 · Start Here › Welcome · 14 Nov 2024 · 3 likes The compound and evidence pages are updated regularly and they are worth reading when you are new. They answer the meta questions like "do we have data on this" and…
-
Time to steady state after a dose increase Replied, post #32 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 0 likes This follows post #29 rather than contradicting it. Bioavailability: oral semaglutide has low bioavailability (roughly 1%) due to peptide instability. That is why the…
-
When "no data" is the complete and final answer Replied, post #13 · Compounds › Other compounds · 1 Nov 2024 · 0 likes Coming back to post #11, because the follow-up matters more than the original answer. Why catalogue breadth is not evidence of anything: a supplier listing 500…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #84 · Clinical › Prescriber conversations · 24 Oct 2024 · 0 likes Discussing side effects: be specific. "Nausea" is less useful than "I have nausea worst 24 to 36 hours after injection, severity 2 to 3 out of 4, stable over weeks".…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #67 · Compounds › Other compounds · 23 Oct 2024 · 0 likes When "no data" is the complete and final answer: if there is no published human data on a compound, that is the state of knowledge. Hope is not a substitute and…
-
Requesting a page: what makes a good request — what changed since Replied, post #25 · Documentation › Wiki requests · 10 Oct 2024 · 0 likes Picking up post #22: that is the part I would want checked first. Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader…
-
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #5 · Clinical › Comorbidities · 26 Sep 2024 · 30 likes Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #46 · Practice › Administration · 22 Sep 2024 · 26 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Signs of dehydration worth acting on Replied, post #17 · Safety › Adverse events · 16 Sep 2024 · 0 likes Reporting to regulatory agencies: if you have had a serious event, reporting it to the regulatory agency in your country can help with signal detection across the…
-
Follow-up: A site rotation scheme that is easy enough to actually follow Replied, post #11 · Practice › Administration · 5 Sep 2024 · 0 likes post #10 is right about the mechanism and I think understates the practical bit. Injection discomfort: comes from needle gauge (finer = less discomfort), volume…
-
Guidelines revision: what changed and why Replied, post #21 · Meta › Announcements · 25 Jul 2024 · 27 likes Archives: older announcements are archived by date. Checking archives is useful if you want to know what changed when.
-
Circumference measurements as a poor man's composition estimate Replied, post #18 · Outcomes › Body composition · 25 Jul 2024 · 9 likes post #17 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Second pass at: Journal club: LEADER as the historical anchor Replied, post #48 · Evidence › Journal club · 21 Jul 2024 · 29 likes Coming back to post #46, because the follow-up matters more than the original answer. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could…
-
The mass-error checker and its intended scope Replied, post #75 · Data & Tools › Calculators · 25 Jun 2024 · 1 like Picking up post #72: that is the part I would want checked first. Titration planning: a calculator that shows you the escalation schedule for different starting and…